Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Enfamil Premature LIPIL

This article was originally published in The Tan Sheet

Executive Summary

New preterm infant formula contains same levels of docosahexaenoic acid, arachidonic acid as regular LIPIL, Mead Johnson says. Launching this month in 3 oz., ready-to-use bottles, formula will be distributed to hospitals, healthcare professionals and direct to consumers through a toll-free number. Mead announced July 9 FDA had no concerns regarding its premarket notification for the product. BMS division says formula's growth, development benefits for preterm infants are demonstrated by studies presented at Pediatric Academic Societies' annual meeting in May (1"The Tan Sheet" April 29, 2002, p. 22). Similac Advance marketer Ross Products says it also expects to launch fortified preterm formula upon agency clearance of its premarket notification. Abbott Labs' division's second quarter sales were flat at $515 mil., company announced July 11...
Advertisement

Related Content

DHA, ARA Benefit Preterm Infants, Research Shows; Formulas On Horizon
DHA, ARA Benefit Preterm Infants, Research Shows; Formulas On Horizon

Topics

Advertisement
UsernamePublicRestriction

Register

PS094264

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel